Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
 Additional Paid in Capital
Accumulated Deficit
Treasury Stock
Beginning Balance (in shares) at Dec. 31, 2018   32,381,290      
Beginning Balance at Dec. 31, 2018 $ 12,946,015 $ 32,759 $ 138,867,509 $ (124,557,694) $ (1,396,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (4,488,107)     (4,488,107)  
Stock-based compensation 789,914   789,914    
Stock issued for vested restricted stock awards (in shares)   765,429      
Stock issued for vested restricted stock awards 0 $ 765 (765)    
Sale of common stock (in shares)   15,812,500      
Sale of common stock 4,414,123 $ 15,812 4,398,311    
Shares withheld for taxes on vested restricted stock (45,565)   (45,565)    
Convertible Note Conversion (in shares)   2,886,792      
Convertible Note Conversion 837,170 $ 2,887 834,283    
Ending Balance (in shares) at Dec. 31, 2019   51,846,011      
Ending Balance at Dec. 31, 2019 14,453,550 $ 52,223 144,843,687 (129,045,801) (1,396,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (7,304,569)     (7,304,569)  
Stock-based compensation 858,683   858,683    
Cancellation of treasury stock 0 $ (376) (1,396,183)   1,396,559
Stock issued for vested restricted stock awards (in shares)   1,020,882      
Stock issued for vested restricted stock awards 0 $ 1,020 (1,020)    
Shares withheld for taxes on vested restricted stock (74,550)   (74,550)    
Convertible Note Conversion (in shares)   3,000,000      
Convertible Note Conversion 923,810 $ 3,000 920,810    
Sale of common stock (in shares)   42,168,936      
Sale of common stock 16,432,190 $ 42,169 16,390,021    
Ending Balance (in shares) at Dec. 31, 2020   98,035,829      
Ending Balance at Dec. 31, 2020 $ 25,289,114 $ 98,036 $ 161,541,448 $ (136,350,370) $ 0